Procyon Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $279K | Sell |
531
-5,942
| -92% | -$3.12M | 0.03% | 380 |
|
|
2025
Q1 | $4.11M | Buy |
6,473
+2,992
| +86% | +$1.9M | 0.25% | 89 |
|
|
2024
Q4 | $2.48M | Sell |
3,481
-544
| -14% | -$387K | 0.16% | 135 |
|
|
2024
Q3 | $4.23M | Buy |
4,025
+244
| +6% | +$256K | 0.29% | 81 |
|
|
2024
Q2 | $3.97M | Buy |
3,781
+308
| +9% | +$324K | 0.29% | 77 |
|
|
2024
Q1 | $3.34M | Buy |
3,473
+268
| +8% | +$258K | 0.26% | 91 |
|
|
2023
Q4 | $2.81M | Buy |
3,205
+174
| +6% | +$153K | 0.24% | 101 |
|
|
2023
Q3 | $2.49M | Buy |
3,031
+1,823
| +151% | +$1.5M | 0.26% | 96 |
|
|
2023
Q2 | $868K | Buy |
+1,208
| New | +$868K | 0.11% | 174 |
|
|
2020
Q3 | – | Sell |
-45
| Closed | -$28K | – | 841 |
|
|
2020
Q2 | $28K | Hold |
45
| – | – | 0.01% | 478 |
|
|
2020
Q1 | $22K | Hold |
45
| – | – | 0.01% | 469 |
|
|
2019
Q4 | $17K | Buy |
+45
| New | +$17K | 0.01% | 528 |
|